|
1
|
Structure based drug design: development of potent and selective factor IXa (FIXa) inhibitors.
|
J Med Chem
|
2010
|
2.28
|
|
2
|
Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling.
|
J Biol Chem
|
2006
|
1.60
|
|
3
|
Studies of benzothiophene template as potent factor IXa (FIXa) inhibitors in thrombosis.
|
J Med Chem
|
2010
|
0.78
|
|
4
|
N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity.
|
Chembiochem
|
2014
|
0.77
|